A new study suggests that combining a breast cancer drug with hormone therapy could be a more effective strategy to reduce the progression and recurrence of prostate cancer in men. Read the article here.
Prostate cancer: Could a breast cancer drug reduce recurrence Read More »
Cleveland Clinic prostate cancer specialists tailor prostate cancer treatment plans to their patients’ needs, taking into account the type of cancer, the age of the individual, the degree to which the cancer has spread and the general health of the patient. Read the Guide here.
Treatment Guide for Prostate Cancer Read More »
September 2017 Awareness Night Brachytherapy for Prostate Cancer and Breast Cancer Dr. Juanita Crook, MD, FRCPC Professor of Radiation Oncology, University of British Columbia Radiation Oncologist, Center for the Southern Interior in Kelowna BC CLICK ON THE ARROW TO START THE VIDEO The Complete Presentation 47:27 minutes
Video: “Brachytherapy for Prostate Cancer and Breast Cancer” Read More »
The latest approach to treating prostate cancer uses nanoparticles of gold and lasers to kill the cancer cells. Read the article here.
Researchers Look To Gold To Help Combat Prostate Cancer Read More »
Predicting outcomes on active surveillance for intermediate-risk patients Read the article here. Active Surveillance for Intermediate-risk Prostate Cancer Challenged Read the article here. Active Surveillance versus Watchful Waiting Read the article here. Surgery isn’t necessarily best for prostate cancer, according to study led by Minneapolis VA Read the article here.
Active Surveillance Read More »
A study by researchers at the UCLA Jonsson Comprehensive Cancer Center provides convincing evidence that radiation-based treatments and surgery are equally effective treatments for aggressive prostate cancer. It also suggests that a particular form of radiation therapy, consisting of external radiation followed by brachytherapy (a type of radiation treatment in which a radioactive source is placed into the tumor directly) provides the best chance of preventing metastatic disease. Read the article here.
High-dose radiation therapy as effective as surgery for aggressive prostate cancer Read More »
Some experts see Cesium-131 as an optimal version of brachytherapy because it is both fast-acting and has a shorter delivery time than other brachytherapies — about 30 days. A key advantage is shorter recuperation periods, meaning patients can recover their urinary, bowel, and sexual functions quicker than with other brachytherapy solutions. Read the article here.
Cesium-131 Brachytherapy Read More »
The Ontario Health Technology Advisory Committee (OHTAC) has recommended against publicly funding robotic surgery for prostate cancer. OHTAC determined there was not enough evidence that the minimally invasive procedure is better than traditional open surgery to justify the increased price of $6,000 per patient. Read article 1 here. Read article 2 here.
Robotic Surgery for Radical Prostatectomy : OHTAC Recommendation Read More »
July 2017 Awareness Night Partial gland ablation for localized prostate cancer: Who is eligible and what are the risks? Dr. Nathan Perlis, MD, MSc, FRCSC Clinical assistant, Division of Urology, University Health Network Clinical fellow, Society of Urological Oncology, University of Toronto CLICK ON THE ARROW TO START THE VIDEO The Complete Presentation 40:48 minutes
From a conference in May 2017, a comprehensive overview of active surveillance by one of the experts in the field. View video.
Video: Active Surveillance: Protecting Patients from Harm – Dr. Laurence Klotz Read More »